Publications

Publications published since 2010 from OUS - Section for head and neck oncology

71 publications found

Publications 2020

1. Clarke M, Mackay A, Ismer B, Pickles JC, Tatevossian RG, Newman S, Bale TA, Stoler I, Izquierdo E, Temelso S, Carvalho DM, Molinari V, Burford A, Howell L, Virasami A, Fairchild AR, Avery A, Chalker J, Kristiansen M, Haupfear K, Dalton JD, Orisme W, Wen J, Hubank M, Kurian KM et al. (2020)
   Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
   Cancer Discov, 10 (7), 942-963
   DOI 10.1158/2159-8290.CD-19-1030, PubMed 32238360
2. Frič R, Due-Tønnessen BJ, Lundar T, Egge A, Kronen Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2020)
   Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood
   Sci Rep, 10 (1), 9371
   DOI 10.1038/s41598-020-66328-8, PubMed 32523021
3. Hauge T, Amdal CD, Falk RS, Johannessen HO, Johnson E (2020)
   Long-term outcome in patients operated with hybrid esophagectomy for esophageal cancer - a cohort study
   Acta Oncol, 59 (7), 859-865
   DOI 10.1080/0284186X.2020.1750694, PubMed 32324079
4. Jeanmougin M, Håvik AB, Cekaite L, Brandal P, Sveen A, Meling TR, Ågesen TH, Scheie D, Heim S, Lothe RA, Lind GE (2020)
   Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment
   Mol Oncol, 14 (5), 1016-1027
   DOI 10.1002/1878-0261.12668, PubMed 32171051
5. Kierulf-Vieira KS, Sandberg CJ, Waaler J, Lund K, Skaga E, Saberniak BM, Panagopoulos I, Brandal P, Krauss S, Langmoen IA, Vik-Mo EO (2020)
   A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
   Cancers (Basel), 12 (6)
   DOI 10.3390/cancers12061630, PubMed 32575464
6. Larsson C, Groote I, Vardal J, Kleppestø M, Odland A, Brandal P, Due-Tønnessen P, Holme SS, Hope TR, Meling TR, Fosse E, Emblem KE, Bjørnerud A (2020)
   Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy
   Magn Reson Imaging, 68, 106-112
   DOI 10.1016/j.mri.2020.01.012, PubMed 32004711
7. Rahman MA, Brekke J, Arnesen V, Hannisdal MH, Navarro AG, Waha A, Herfindal L, Rygh CB, Bratland E, Brandal P, Haasz J, Oltedal L, Miletic H, Lundervold A, Lie SA, Goplen D, Chekenya M (2020)
   Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study
   Immun Inflamm Dis
   DOI 10.1002/iid3.315, PubMed 32578964
8. Stadskleiv K, Stensvold E, Stokka K, Bechensteen AG, Brandal P (2020)
   Neuropsychological functioning in survivors of childhood medulloblastoma/CNS-PNET: The role of secondary medical complications
   Clin Neuropsychol, 1-26 (in press)
   DOI 10.1080/13854046.2020.1794045, PubMed 32729777
9. Stensvold E, Stadskleiv K, Myklebust TÅ, Wesenberg F, Helseth E, Bechensteen AG, Brandal P (2020)
   Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors
   Acta Paediatr
   DOI 10.1111/apa.15188, PubMed 31977119
10. Witt Nyström P, Bratland Å, Minn H, Grau C (2020)
    Ongoing and future clinical trials in particle therapy in the Nordic countries
    Acta Oncol
    DOI 10.1080/0284186X.2020.1792548, PubMed 32673134

Publications 2019

1. Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019)
   18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
   Clin Nucl Med, 44 (8), 605-611
   DOI 10.1097/RLU.0000000000002641, PubMed 31274605
2. Brandstorp-Boesen J, Zätterström U, Evensen JF, Boysen M (2019)
   Value of patient-reported symptoms in the follow up of patients potentially cured of laryngeal carcinoma
   J Laryngol Otol, 133 (6), 508-514
   DOI 10.1017/S0022215119000677, PubMed 31006407
3. Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D, KEYNOTE-048 Investigators (2019)
   Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
   Lancet, 394 (10212), 1915-1928
   DOI 10.1016/S0140-6736(19)32591-7, PubMed 31679945
4. Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J (2019)
   DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)
   Acta Oncol, 58 (10), 1502-1505
   DOI 10.1080/0284186X.2019.1629012, PubMed 31282236
5. Latysheva A, Emblem KE, Brandal P, Vik-Mo EO, Pahnke J, Røysland K, Hald JK, Server A (2019)
   Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach
   Neuroradiology, 61 (5), 545-555
   DOI 10.1007/s00234-019-02173-5, PubMed 30712139
6. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2019)
   Adult outcome after neurosurgical treatment of brain tumours in the first year of life: long-term follow-up of a single consecutive institutional series of 34 patients
   Acta Neurochir (Wien), 161 (9), 1793-1798
   DOI 10.1007/s00701-019-04014-z, PubMed 31309304
7. Moan JM, Amdal CD, Malinen E, Svestad JG, Bogsrud TV, Dale E (2019)
   The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status
   Radiother Oncol, 140, 54-61
   DOI 10.1016/j.radonc.2019.05.019, PubMed 31177043
8. Röhrl K, Guren MG, Astrup GL, Småstuen MC, Rustøen T (2019)
   High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study
   Eur J Oncol Nurs, 44, 101679
   DOI 10.1016/j.ejon.2019.101679, PubMed 31751848
9. Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N, Bonomo P, Sherman AC, Baumann I, Galalae R, Fernandez Gonzalez L, Nicolatou-Galitis O, Abdel-Hafeez Z, Raber-Durlacher J, Schmalz C, Zotti P, Boehm A et al. (2019)
   International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
   Head Neck, 41 (6), 1725-1737
   DOI 10.1002/hed.25609, PubMed 30636188
10. Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P (2019)
    Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival
    Pediatr Blood Cancer, 66 (10), e27910
    DOI 10.1002/pbc.27910, PubMed 31264356
11. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
    Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
    Acta Oncol, 58 (10), 1416-1422
    DOI 10.1080/0284186X.2019.1643496, PubMed 31364899
12. Sunde B, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Rouvelas I, Wang N, Lundell L, Lagergren P, Nilsson M (2019)
    Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy069, PubMed 30084992
13. Sunde B, Klevebro F, Johar A, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Ajengui A, Lundell L, Lagergren P, Nilsson M (2019)
    Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial)
    Br J Surg, 106 (11), 1452-1463
    DOI 10.1002/bjs.11246, PubMed 31436322
14. von Döbeln GA, Klevebro F, Jacobsen AB, Johannessen HO, Nielsen NH, Johnsen G, Hatlevoll I, Glenjen NI, Friesland S, Lundell L, Yu J, Nilsson M (2019)
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy078, PubMed 30137281

Publications 2018

1. Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG (2018)
   Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
   Acta Oncol, 57 (9), 1159-1164
   DOI 10.1080/0284186X.2018.1464664, PubMed 29771169
2. Dale E, Waldeland E (2018)
   Proton therapy - a reality in Norway from 2023
   Tidsskr Nor Laegeforen, 138 (13)
   DOI 10.4045/tidsskr.18.0250, PubMed 30180494
3. Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
   Patients know their own health best
   Tidsskr. Nor. Laegeforen., 138 (8), 716-718
4. Johannessen LE, Brandal P, Myklebust TÅ, Heim S, Micci F, Panagopoulos I (2018)
   MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas
   Cancer Genomics Proteomics, 15 (6), 437-446
   DOI 10.21873/cgp.20102, PubMed 30343277
5. Lundar T, Due-Tønnessen BJ, Fric R, Egge A, Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2018)
   Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients
   Acta Neurochir (Wien), 160 (6), 1207-1214
   DOI 10.1007/s00701-018-3550-8, PubMed 29680921
6. Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C (2018)
   DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
   Radiother Oncol, 127 (1), 12-19
   DOI 10.1016/j.radonc.2018.02.018, PubMed 29523409
7. Panagopoulos I, Gorunova L, Leske H, Niehusmann P, Johannessen LE, Staurseth J, Øino N, Meling TR, Heim S, Micci F, Brandal P (2018)
   Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma
   Cancer Genomics Proteomics, 15 (5), 379-385
   DOI 10.21873/cgp.20096, PubMed 30194078
8. Skjøtskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, Malinen E, Dale E (2018)
   Dose painting for re-irradiation of head and neck cancer
   Acta Oncol, 57 (12), 1693-1699
   DOI 10.1080/0284186X.2018.1512753, PubMed 30280623

Publications 2017

1. Amdal CD, Jacobsen AB, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K (2017)
   Improved treatment decisions in patients with esophageal cancer
   Acta Oncol, 56 (10), 1286-1294
   DOI 10.1080/0284186X.2017.1346379, PubMed 28686501
2. Astrup GL, Hofsø K, Bjordal K, Guren MG, Vistad I, Cooper B, Miaskowski C, Rustøen T (2017)
   Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence
   Acta Oncol, 56 (3), 462-470
   DOI 10.1080/0284186X.2016.1273546, PubMed 28077018
3. Astrup GL, Rustøen T, Hofsø K, Gran JM, Bjordal K (2017)
   Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy
   Head Neck, 39 (10), 2114-2126
   DOI 10.1002/hed.24875, PubMed 28766791
4. Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E (2017)
   Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery
   Eur Arch Otorhinolaryngol, 274 (12), 4203-4209
   DOI 10.1007/s00405-017-4764-8, PubMed 29019001
5. Johansen S, Norman MH, Dale E, Amdal CD, Furre T, Malinen E, Evensen JF (2017)
   Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer
   Radiat Oncol, 12 (1), 87
   DOI 10.1186/s13014-017-0829-5, PubMed 28545588
6. König M, Osnes T, Jebsen P, Evensen JF, Meling TR (2017)
   Olfactory neuroblastoma: a single-center experience
   Neurosurg Rev, 41 (1), 323-331
   DOI 10.1007/s10143-017-0859-3, PubMed 28540633
7. Leske H, Brandal P, Rushing EJ, Niehusmann P (2017)
   IDH-mutant giant cell glioblastoma: A neglected tumor variant?
   Clin Neuropathol, 36 (6), 293-295
   DOI 10.5414/NP301054, PubMed 29035191
8. Mikalsen LTG, Arnesen MR, Bogsrud TV, Dale E, Stokke C (2017)
   Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer
   Acta Oncol, 56 (6), 894-897
   DOI 10.1080/0284186X.2017.1286384, PubMed 28464741
9. Mäkitie AA, Cange HH, Hammarstedt-Nordenvall L, Gudjonsson A, Jóhannsson J, Laranne J, Mäenpää H, Rikardsen O, Bratland Å, Wessel I, Johansen J, Grau C (2017)
   Head and neck cancer management in the Nordic countries: an effort to harmonize treatment
   Eur Arch Otorhinolaryngol, 274 (5), 2363-2365
   DOI 10.1007/s00405-017-4456-4, PubMed 28124110
10. Stensvold E, Krossnes BK, Lundar T, Due-Tønnessen BJ, Frič R, Due-Tønnessen P, Bechensteen AG, Myklebust TÅ, Johannesen TB, Brandal P (2017)
    Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment
    Acta Oncol, 56 (5), 698-705
    DOI 10.1080/0284186X.2017.1301679, PubMed 28325133

Publications 2016

1. Boysen ME, Zätterström UK, Evensen JF (2016)
   Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases
   Anticancer Res, 36 (6), 2849-54
   PubMed 27272796
2. Dale E, Moan JM, Osnes TA, Bogsrud TV (2016)
   Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome
   Eur Arch Otorhinolaryngol, 274 (2), 1015-1019
   DOI 10.1007/s00405-016-4318-5, PubMed 27671150
3. Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T (2016)
   Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
   Eur Heart J, 37 (21), 1671-80
   DOI 10.1093/eurheartj/ehw022, PubMed 26903532
4. Hjermstad MJ, Bergenmar M, Bjordal K, Fisher SE, Hofmeister D, Montel S, Nicolatou-Galitis O, Pinto M, Raber-Durlacher J, Singer S, Tomaszewska IM, Tomaszewski KA, Verdonck-de Leeuw I, Yarom N, Winstanley JB, Herlofson BB, EORTC QoL Group (2016)
   International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15
   Support Care Cancer, 24 (9), 3915-24
   DOI 10.1007/s00520-016-3216-0, PubMed 27113466
5. Klevebro F, Alexandersson von Döbeln G, Wang N, Johnsen G, Jacobsen AB, Friesland S, Hatlevoll I, Glenjen NI, Lind P, Tsai JA, Lundell L, Nilsson M (2016)
   A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
   Ann Oncol, 27 (4), 660-7
   DOI 10.1093/annonc/mdw010, PubMed 26782957
6. Olsen TK, Panagopoulos I, Gorunova L, Micci F, Andersen K, Kilen Andersen H, Meling TR, Due-Tønnessen B, Scheie D, Heim S, Brandal P (2016)
   Novel fusion genes and chimeric transcripts in ependymal tumors
   Genes Chromosomes Cancer, 55 (12), 944-953
   DOI 10.1002/gcc.22392, PubMed 27401149
7. Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P (2016)
   Persistent bone marrow depression following short-term treatment with temozolomide
   BMJ Case Rep, 2016
   DOI 10.1136/bcr-2016-215797, PubMed 27130558
8. Varghese M, Nymoen HG, Saxhaug C, Krossnes B, Abdol Mohieb Hosainey S, Meling TR, Brandal P (2016)
   Symptomatic spinal metastasis from intracranial glioblastoma multiforme - Two illustrative cases and a review of the literature
   Acta Oncol, 55 (9-10), 1236-1238
   DOI 10.3109/0284186X.2016.1161824, PubMed 27174685

Publications 2015

1. Arnesen MR, Knudtsen IS, Rekstad BL, Eilertsen K, Dale E, Bruheim K, Helland Å, Løndalen AM, Hellebust TP, Malinen E (2015)
   Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps
   Acta Oncol, 54 (9), 1607-13
   DOI 10.3109/0284186X.2015.1061690, PubMed 26213311
2. Astrup GL, Rustøen T, Miaskowski C, Paul SM, Bjordal K (2015)
   A Longitudinal Study of Depressive Symptoms in Patients With Head and Neck Cancer Undergoing Radiotherapy
   Cancer Nurs, 38 (6), 436-46
   DOI 10.1097/NCC.0000000000000225, PubMed 25643005
3. Astrup GL, Rustøen T, Miaskowski C, Paul SM, Bjordal K (2015)
   Changes in and predictors of pain characteristics in patients with head and neck cancer undergoing radiotherapy
   Pain, 156 (5), 967-79
   DOI 10.1097/j.pain.0000000000000142, PubMed 25719616
4. Cehajic I, Bergan S, Bjordal K (2015)
   Pharmacist assessment of drug-related problems on an oncology ward
   Eur. J. Hosp. Pharm.-Sci. Pract., 22 (4), 194-197
5. Due-Tønnessen BJ, Egge A, Lundar T, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
   Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy
   Springerplus, 4, 389
   DOI 10.1186/s40064-015-1178-1, PubMed 26251773
6. Klevebro F, Johnsen G, Johnson E, Viste A, Myrnäs T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M (2015)
   Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
   Eur J Surg Oncol, 41 (7), 920-6
   DOI 10.1016/j.ejso.2015.03.226, PubMed 25908010
7. Lundar T, Due-Tønnessen BJ, Egge A, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
   Neurosurgical treatment of brain tumors in the first 6 months of life: long-term follow-up of a single consecutive institutional series of 30 patients
   Childs Nerv Syst, 31 (12), 2283-90
   DOI 10.1007/s00381-015-2792-5, PubMed 26174616
8. Lyhne NM, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Evensen J, Mortensen HR, Overgaard J (2015)
   The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma
   Radiother Oncol, 117 (1), 91-8
   DOI 10.1016/j.radonc.2015.07.004, PubMed 26255764
9. Olsen TK, Panagopoulos I, Meling TR, Micci F, Gorunova L, Thorsen J, Due-Tønnessen B, Scheie D, Lund-Iversen M, Krossnes B, Saxhaug C, Heim S, Brandal P (2015)
   Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
   Neuro Oncol, 17 (10), 1365-73
   DOI 10.1093/neuonc/nov039, PubMed 25795305

Publications 2014

1. Dale E (2014)
   [Re: Brachytherapy for malignant uveal melanoma]
   Tidsskr Nor Laegeforen, 134 (8), 814
   DOI 10.4045/tidsskr.14.0467, PubMed 24780973
2. Hofsø K, Bjordal K, Diep LM, Rustøen T (2014)
   The relationships between demographic and clinical characteristics and quality of life during and after radiotherapy: in women with breast cancer
   Qual Life Res, 23 (10), 2769-77
   DOI 10.1007/s11136-014-0736-2, PubMed 24952109
3. Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG, Overgaard J, Danish Head and Neck Cancer Group (DAHANCA) (2014)
   Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
   Radiother Oncol, 113 (3), 310-6
   DOI 10.1016/j.radonc.2014.11.032, PubMed 25544647
4. von der Lippe C, Roscher I, Nordgarden H, Rustad C, Larsen SM, Mjøen E, Bratland Å (2014)
   Man with macrocephaly, learning disability and multiple basal cell carcinomas
   Tidsskr Nor Laegeforen, 134 (11), 1151-4
   DOI 10.4045/tidsskr.13.0894, PubMed 24939783
5. Zätterström U, Boysen M, Evensen JF (2014)
   Significance of self-reported symptoms as part of follow-up routines in patients treated for oral squamous cell carcinoma
   Anticancer Res, 34 (11), 6593-9
   PubMed 25368263

Publications 2013

1. Amdal CD, Jacobsen AB, Sandstad B, Warloe T, Bjordal K (2013)
   Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
   Radiother Oncol, 107 (3), 428-33
   DOI 10.1016/j.radonc.2013.04.008, PubMed 23647761
2. Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T (2013)
   [Cardioprotective treatment during adjuvant cancer therapy]
   Tidsskr Nor Laegeforen, 133 (17), 1832-6
   DOI 10.4045/tidsskr.12.1514, PubMed 24042297
3. Lindviksmoen G, Hofsø K, Paul SM, Miaskowski C, Rustøen T (2013)
   Predictors of initial levels and trajectories of depressive symptoms in women with breast cancer undergoing radiation therapy
   Cancer Nurs, 36 (6), E34-43
   DOI 10.1097/NCC.0b013e31826fc9cc, PubMed 23132125

Publications 2012

1. Amdal CD, Jacobsen AB, Guren MG, Bjordal K (2012)
   Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review
   Acta Oncol, 52 (4), 679-90
   DOI 10.3109/0284186X.2012.731521, PubMed 23190360

Publications 2011

1. Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Sandstad B, Bjordal K (2011)
   Palliative interventions and prognosis in patients with advanced esophageal cancer
   Dis Esophagus, 24 (7), 502-9
   DOI 10.1111/j.1442-2050.2010.01174.x, PubMed 21309923

Publications 2010

1. Dale E, Hårsaker V, Kristoffersen DT, Bruland O, Olsen DR (2010)
   CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial
   Strahlenther Onkol, 186 (3), 163-8
   DOI 10.1007/s00066-010-2040-6, PubMed 20165821
2. Wranicz P, Herlofson BB, Evensen JF, Kongsgaard UE (2010)
   Prevention and treatment of trismus in head and neck cancer: A case report and a systematic review of the literature
   Scand J Pain, 1 (2), 84-88
   DOI 10.1016/j.sjpain.2010.01.006, PubMed 29913945